• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-04-22

  This study benchmarks biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, both coupled with mass spectrometry, for predicting the lung permeability of pharmaceuticals. The findings provide a robust analytical platform for high-throughput screening in respiratory drug development, informing the selection and optimization of anti-inflammatory corticosteroids such as Budesonide.

• Hypoxia and Immunometabolism: Mechanisms in Tumor Microenvir

  2026-04-22

  This review synthesizes recent insights into how hypoxia-driven metabolic reprogramming and immunometabolism shape the tumor microenvironment (TME), emphasizing the mechanisms of immune evasion and metabolic competition. The findings highlight the importance of glucose metabolism in tumor progression and immunosuppressive niche formation, with implications for developing targeted therapies.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-04-21

  This study systematically investigates the prevalence, genetic context, and transmission mechanisms of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. By revealing high rates of multidrug resistance and efficient gene transfer, the work delivers critical insights for researchers developing resistance surveillance and experimental protocols.

• ATRX Loss Sensitizes High-Grade Glioma to RTK/PDGFR Inhibito

  2026-04-21

  This study identifies that ATRX-deficient high-grade glioma cells exhibit increased sensitivity to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. These findings provide a rationale for stratifying glioma patients by ATRX status in clinical trials of multi-targeted kinase inhibitors and inform precision therapeutic strategies.

• Diphenyleneiodonium Chloride: Applied Redox and cAMP Modulat

  2026-04-20

  Diphenyleneiodonium chloride (DPI) stands out as a gold-standard probe for dissecting redox enzyme function and cAMP signaling, empowering advanced research in oxidative stress and cell signaling. This article integrates recent breakthroughs on Nrf2 pathway regulation with actionable workflow guidance, troubleshooting, and comparative insights to maximize experimental reproducibility.

• MVC Triggers RhoA/ROCK1 Pathway to Disrupt Tight Junctions

  2026-04-20

  This study elucidates how the Minute Virus of Canines (MVC) directly engages the RhoA/ROCK1/MLC2 signaling axis to disrupt epithelial tight junctions, facilitating occludin-mediated viral entry. The identification of VP2-ROCK1 interaction and pathway dependency advances our understanding of viral pathogenesis and highlights potential molecular targets for antiviral intervention.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-04-19

  This study reveals that inhibiting DOT1L, a histone H3K79 methyltransferase, reprograms innate immunity and amplifies the anti-myeloma activity of immunomodulatory drugs such as lenalidomide. Mechanistic insights demonstrate epigenetic-immune crosstalk and highlight a new avenue for improving multiple myeloma therapies.

• Bortezomib (PS-341): Optimizing Apoptosis Assays with SKU A2

  2026-04-18

  This article addresses real-world challenges in apoptosis and cell viability assays, demonstrating how Bortezomib (PS-341) (SKU A2614) from APExBIO offers reproducibility, validated protocol guidance, and robust performance. Researchers will find evidence-based solutions and workflow optimizations tailored for multiple myeloma, lymphoma, and broader proteasome-regulated studies.

• Preserving Native Structure: Strategic Leverage of Native PA

  2026-04-17

  This article unpacks how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) from APExBIO enables translational researchers to achieve high-resolution, activity-preserving separation of acidic proteins. We bridge mechanistic details of native protein electrophoresis to recent advances in synthetic lethality research, spotlighting strategic opportunities for therapeutic discovery and functional proteomics. Anchored by evidence from clear cell renal cell carcinoma studies, and building on prior expert commentary, we offer actionable insights for researchers seeking to bridge bench and bedside.

• DiscoveryProbe Bioactive Compound Library Plus: Optimizing H

  2026-04-16

  Leverage the DiscoveryProbe Bioactive Compound Library Plus to drive high-throughput ligand screening, pathway mapping, and protease inhibitor discovery with robust quality control and workflow efficiency. This guide delivers actionable protocols, troubleshooting intelligence, and practical integration of the latest evidence in ligand-based assay design.

• Reliable Plasmid DNA Extraction: ApexPrep DNA Plasmid Minipr

  2026-04-15

  This article addresses frequent laboratory challenges in plasmid DNA extraction for cell-based assays, focusing on the ApexPrep DNA Plasmid Miniprep Kit (SKU A5001). Drawing on quantitative data and real-world scenarios, we analyze how this kit ensures molecular biology grade plasmid DNA for cloning, sequencing, and functional studies, with evidence-backed guidance for workflow optimization.

• Mitochondrial Calcium Signaling Regulates Ferroptosis via GP

  2026-04-14

  This study uncovers a mechanistic link between mitochondrial calcium uptake through the MCU and the regulation of ferroptosis via acetylation of GPX4. The findings demonstrate that mitochondrial calcium signaling sustains GPX4 activity, thereby repressing ferroptotic cell death, with implications for cancer biology and acute organ injury research.

• Midecamycin: Rigorous Quantitation and Assay Optimization in

  2026-04-13

  Explore the advanced use of midecamycin, a key acetoxy-substituted macrolide antibiotic, for precise antibacterial assay optimization. This article uniquely focuses on evidence-based protocols and actionable insights for microbiology researchers.

• SU 5402: Potent Multi-Kinase Inhibitor for Cancer & Myeloma

  2026-04-13

  SU 5402 (A3843) is a well-characterized small molecule inhibitor targeting VEGFR2, FGFR1, and PDGFRβ. It induces cell cycle arrest and apoptosis in select cancer cell lines, making it central for multiple myeloma research and therapeutic target validation.

• EGCG in Translational Research: Mechanisms, Strategies, Outl

  2026-04-12

  (-)-Epigallocatechin gallate (EGCG) stands at the crossroads of antioxidant, antiangiogenic, antiviral, and chemopreventive research. In this thought-leadership article, we decode its mechanistic underpinnings, dissect the persistent translational challenges—such as intracellular pathogen clearance and bioavailability—and provide actionable guidance for integrating EGCG into preclinical workflows. Drawing on recent peer-reviewed findings, including novel EGCG analogs in the fight against Staphylococcus aureus, we position APExBIO's EGCG as a validated, versatile tool poised to accelerate discovery.

15593 records 1/1040 page Next 12345 下5页 Last page